Please enable JavaScript to continue using this application.

Compare $ODTX vs $SANA | Chartloom

Compare

$ODTX vs $SANA

Odyssey Therapeutics Inc · Sana Biotechnology Inc

ODTX

Odyssey Therapeutics Inc

SANA

Sana Biotechnology Inc

Compare $ODTX vs $SANA

Comparing Odyssey Therapeutics Inc and Sana Biotechnology Inc

ODTXOdyssey Therapeutics Inc

SANASana Biotechnology Inc

ODTXOdyssey Therapeutics Inc

Market cap

$913M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.0%

YTD performance

15.7%

52W performance

15.7%

FCF yield

-4.2%

SANASana Biotechnology Inc

Market cap

$776M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-33.4%

52W performance

-38.4%

FCF yield

-17.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ODTX

SANA

Detailed metrics comparison

ODTX

Odyssey Therapeutics Inc

SANA

Sana Biotechnology Inc

Market Cap

ODTX$913M

SANA$776M

Enterprise Value

ODTX$831M

SANA$719M

Price

ODTX$19.00

SANA$2.79

P/E Ratio

ODTXN/A

SANAN/A

P/S Ratio

ODTX306.64x

SANA0.00x

EV/Sales

ODTX279.08x

SANA0.00x

EV/EBITDA

ODTX0.00x

SANA0.00x

P/B Ratio

ODTX2.36x

SANA5.60x

P/FCF Ratio

ODTXN/A

SANAN/A

EV/FCF

ODTX-21.89x

SANA-5.33x

PEG Ratio

ODTXN/A

SANAN/A

Forward P/E (NTM)

ODTXN/A

SANAN/A

Forward P/S (NTM)

ODTXN/A

SANAN/A

Revenue (TTM)

ODTX$3M

SANA$0

Revenue Growth (YoY)

ODTX-19.0%

SANAN/A

Forward Rev Growth

ODTX410.3%

SANA427.6%

Gross Margin (TTM)

ODTX0.0%

SANA0.0%

Operating Margin (TTM)

ODTX0.0%

SANA0.0%

EBITDA Margin (TTM)

ODTX-3193.4%

SANA0.0%

Net Margin (TTM)

ODTX-8054.3%

SANA0.0%

FCF Margin (TTM)

ODTX-1275.0%

SANAN/A

Net Income (TTM)

ODTX$-240M

SANA$-212M

FCF (TTM)

ODTX$-38M

SANA$-135M

EPS (TTM)

ODTX-$7.92

SANA-$0.72

ROE (TTM)

ODTX-3030.0%

SANA-13449.0%

ROA (TTM)

ODTX-2554.0%

SANA-5112.0%

ROIC (TTM)

ODTX-3030.0%

SANA-13449.0%

Cash

ODTX$82M

SANA$57M

Debt

ODTX$0

SANA$0

Net Cash/Debt

ODTX$82M

SANA$57M

Current Ratio (TTM)

ODTX11.36x

SANA1.38x

Quick Ratio (TTM)

ODTX10.98x

SANA1.33x

Debt/Equity (TTM)

ODTX0.00x

SANA0.00x

Debt/Assets (TTM)

ODTX0.0%

SANA0.0%

Interest Coverage (TTM)

ODTXN/A

SANAN/A

Net Debt/EBITDA (TTM)

ODTX0.00x

SANA0.00x

Beta

ODTX-0.23

SANA2.31

52W Performance

ODTX15.7%

SANA-38.4%

YTD Performance

ODTX15.7%

SANA-33.4%

% from 52W High

ODTX-34.6%

SANA-57.4%

% from 52W Low

ODTX25.8%

SANA6.9%

Asset Turnover (TTM)

ODTX0.00x

SANA0.00x

FCF Yield (TTM)

ODTX-4.2%

SANA-17.4%

Earnings Yield (TTM)

ODTX-26.3%

SANA-27.3%

Dividend Yield (TTM)

ODTXN/A

SANAN/A

Rule of 40

ODTX-1,294.1

SANA0.0

EV/GP/RG

ODTXN/A

SANAN/A

Ticker research

View ODTX research View SANA research

Metric	ODTX Odyssey Therapeutics Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$913M	$776M
Enterprise Value	$831M	$719M
Price	$19.00	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	306.64x	0.00x
EV/Sales	279.08x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.36x	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.89x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3M	$0
Revenue Growth (YoY)	-19.0%	N/A
Forward Rev Growth	410.3%	427.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3193.4%	0.0%
Net Margin (TTM)	-8054.3%	0.0%
FCF Margin (TTM)	-1275.0%	N/A
Net Income (TTM)	$-240M	$-212M
FCF (TTM)	$-38M	$-135M
EPS (TTM)	-$7.92	-$0.72
ROE (TTM)	-3030.0%	-13449.0%
ROA (TTM)	-2554.0%	-5112.0%
ROIC (TTM)	-3030.0%	-13449.0%
Financial Health
Cash	$82M	$57M
Debt	$0	$0
Net Cash/Debt	$82M	$57M
Current Ratio (TTM)	11.36x	1.38x
Quick Ratio (TTM)	10.98x	1.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.23	2.31
52W Performance	15.7%	-38.4%
YTD Performance	15.7%	-33.4%
% from 52W High	-34.6%	-57.4%
% from 52W Low	25.8%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-4.2%	-17.4%
Earnings Yield (TTM)	-26.3%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,294.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ODTX research	View SANA research

Valuation

P/S Ratio

SANA

0.00x

ODTX

306.64x

EV/FCF

ODTX

-21.89x

SANA

-5.33x

Growth & revenue

Revenue Growth TTM

ODTX

-19.0%

Forward Revenue Growth

SANA

427.6%

ODTX

410.3%

Profitability & performance

Gross Margin

ODTX

0.0%

SANA

0.0%

ROE

ODTX

-3030.0%

SANA

-13449.0%

FCF Yield %

ODTX

-4.2%

SANA

-17.4%

52-Week Performance

ODTX

15.7%

SANA

-38.4%

Detailed metrics comparison

ODTX

Odyssey Therapeutics Inc

SANA

Sana Biotechnology Inc

Market Cap

ODTX$913M

SANA$776M

Enterprise Value

ODTX$831M

SANA$719M

Price

ODTX$19.00

SANA$2.79

P/E Ratio

ODTXN/A

SANAN/A

P/S Ratio

ODTX306.64x

SANA0.00x

EV/Sales

ODTX279.08x

SANA0.00x

EV/EBITDA

ODTX0.00x

SANA0.00x

P/B Ratio

ODTX2.36x

SANA5.60x

P/FCF Ratio

ODTXN/A

SANAN/A

EV/FCF

ODTX-21.89x

SANA-5.33x

PEG Ratio

ODTXN/A

SANAN/A

Forward P/E (NTM)

ODTXN/A

SANAN/A

Forward P/S (NTM)

ODTXN/A

SANAN/A

Revenue (TTM)

ODTX$3M

SANA$0

Revenue Growth (YoY)

ODTX-19.0%

SANAN/A

Forward Rev Growth

ODTX410.3%

SANA427.6%

Gross Margin (TTM)

ODTX0.0%

SANA0.0%

Operating Margin (TTM)

ODTX0.0%

SANA0.0%

EBITDA Margin (TTM)

ODTX-3193.4%

SANA0.0%

Net Margin (TTM)

ODTX-8054.3%

SANA0.0%

FCF Margin (TTM)

ODTX-1275.0%

SANAN/A

Net Income (TTM)

ODTX$-240M

SANA$-212M

FCF (TTM)

ODTX$-38M

SANA$-135M

EPS (TTM)

ODTX-$7.92

SANA-$0.72

ROE (TTM)

ODTX-3030.0%

SANA-13449.0%

ROA (TTM)

ODTX-2554.0%

SANA-5112.0%

ROIC (TTM)

ODTX-3030.0%

SANA-13449.0%

Cash

ODTX$82M

SANA$57M

Debt

ODTX$0

SANA$0

Net Cash/Debt

ODTX$82M

SANA$57M

Current Ratio (TTM)

ODTX11.36x

SANA1.38x

Quick Ratio (TTM)

ODTX10.98x

SANA1.33x

Debt/Equity (TTM)

ODTX0.00x

SANA0.00x

Debt/Assets (TTM)

ODTX0.0%

SANA0.0%

Interest Coverage (TTM)

ODTXN/A

SANAN/A

Net Debt/EBITDA (TTM)

ODTX0.00x

SANA0.00x

Beta

ODTX-0.23

SANA2.31

52W Performance

ODTX15.7%

SANA-38.4%

YTD Performance

ODTX15.7%

SANA-33.4%

% from 52W High

ODTX-34.6%

SANA-57.4%

% from 52W Low

ODTX25.8%

SANA6.9%

Asset Turnover (TTM)

ODTX0.00x

SANA0.00x

FCF Yield (TTM)

ODTX-4.2%

SANA-17.4%

Earnings Yield (TTM)

ODTX-26.3%

SANA-27.3%

Dividend Yield (TTM)

ODTXN/A

SANAN/A

Rule of 40

ODTX-1,294.1

SANA0.0

EV/GP/RG

ODTXN/A

SANAN/A

Ticker research

View ODTX research View SANA research

Metric	ODTX Odyssey Therapeutics Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$913M	$776M
Enterprise Value	$831M	$719M
Price	$19.00	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	306.64x	0.00x
EV/Sales	279.08x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.36x	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.89x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3M	$0
Revenue Growth (YoY)	-19.0%	N/A
Forward Rev Growth	410.3%	427.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3193.4%	0.0%
Net Margin (TTM)	-8054.3%	0.0%
FCF Margin (TTM)	-1275.0%	N/A
Net Income (TTM)	$-240M	$-212M
FCF (TTM)	$-38M	$-135M
EPS (TTM)	-$7.92	-$0.72
ROE (TTM)	-3030.0%	-13449.0%
ROA (TTM)	-2554.0%	-5112.0%
ROIC (TTM)	-3030.0%	-13449.0%
Financial Health
Cash	$82M	$57M
Debt	$0	$0
Net Cash/Debt	$82M	$57M
Current Ratio (TTM)	11.36x	1.38x
Quick Ratio (TTM)	10.98x	1.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.23	2.31
52W Performance	15.7%	-38.4%
YTD Performance	15.7%	-33.4%
% from 52W High	-34.6%	-57.4%
% from 52W Low	25.8%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-4.2%	-17.4%
Earnings Yield (TTM)	-26.3%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,294.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ODTX research	View SANA research